Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
texas blog main
texas top stories
4
×
boston blog main
detroit blog main
detroit top stories
ipo
medical devices
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
allergan
biogen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
crispr
deals
exome
fda
funding
indiana blog main
indiana top stories
m&a
nash
national
novartis
What
years
4
×
bio
ipo
roundup
sciences
acelity
acquisitions
admits
ago
allogene
announced
antonio
big
biotechs
cancer
ceo
classes
collabs
combinator
companies
company
consortium
covid
crispr
daniel
deal
diversity
dug
equity
eyes
firms
gilead
gilead’s
help
hot
immunotherapy
incubator
initial
introduce
investors
Language
unset
Current search:
years
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More